Companies Related to "Trans-MAPP II Study of Urologic Chronic Pelvin Pain" [Most Relevant Company Matches] - Page: 5 RSS

12:26 EDT 2nd April 2020 | BioPortfolio

Here are the most relevant search results for "Trans-MAPP II Study of Urologic Chronic Pelvin Pain" found in our extensive corporate database of over 50,000 company records.

Showing "Trans MAPP Study Urologic Chronic Pelvin Pain" Companies 101–125 of 2,000+


Colby Pharmaceutical Company

Colby is a privately held company based in Madison, WI and San Jose, CA. Colby is developing new oral small molecule signal transduction modulator drugs and immune modulator biopharmaceuticals for cancer, chronic inflammation, pain, infectious diseases, and neurodegenerative diseases. Colby’s lead small molecule candidates have unique mechanisms of ac...

Bioscience Association Manitoba

Read the study here:

Physican’s Technology, LLC

Developed by a dedicated team of doctors, pain researchers, and computer scientists, the WilloMD iLaserX is a drug-free solution for people who cannot take on pain medication. The team discovered bio-therapeutic technology that is safer and more gentle than existing therapeutic pain laser technology.


Vapogenix, based in Houston, TX, is a clinical stage company developing a new class of topical, non-opioid analgesics to alleviate pain. While most pain is localized, most pain medications are administered orally, which often results in systemic side effects. Vapogenix is focused on treating pain locally – at its source. The Company’s products are volatile anesthetics (VAs) formulated f...

ACADIA Pharmaceuticals Inc.

ACADIA is a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders. ACADIA is currently developing a portfolio consisting of four product candidates including pimavanserin, which is being developed for three separate neurological and psychiatric indi...

The Partnership to Fight Chronic Disease New Jersey

The Partnership to Fight Chronic Disease (PFCD) is an internationally-recognized NGO of patients, providers, community organizations, business and labor groups, and health policy experts committed to raising awareness of the number one cause of death, disability, and rising health care costs: chronic disease. For a collection of statistics and commentary o...


Aranesp® (darbepoetin alfa) is indicated for the treatment of anemia associated with chronic renal failure (CRF), including patients on dialysis and patients not on dialysis, and for the treatment of anemia in patients with nonmyeloid malignancies where anemia is due to the effect of concomitantly administered chemotherapy.Important Product Safety InformationAranesp® is contraindicated in patien...

Fibromyalgia is the most common chronic widespread pain condition in the United States. Studies indicate that at least 6 million Americans suffer from Fibromyalgia, but estimates range as high as 10 to 12 million people. Between 80-90 percent of people diagnosed with Fibromyalgia are women.

TorreyPines Therapeutics

We are a clinical stage biopharmaceutical company committed to discovering, developing and commercializing novel small molecules to treat diseases and disorders of the central nervous system (CNS). Our initial focus is on delivering potentially next generation therapies for chronic pain, including migraine, and cognitive disorders such as cognitive impairment associated with schizophrenia (CIAS) a...


The body is as much electrical as it is chemical.... Diapulse â is a new approach for wound care. The proprietary Diapulse Technology is a safe, cost-effective treatment of post-operative edema and pain in superficial soft tissue in acute and chronic wounds. Diapulse ,simple to use, is an excellent adjunct for patient recovery.

SeprOx Corporation

SeprOx Corporation, located in The Woodlands, TX, was established in 2008 as a wholly owned subsidiary of Trans Ionics Corporation (TIC) to scale up and commercialize groundbreaking technology capable of separating virtually pure oxygen from air using a proprietary membrane material under exclusive license from the Texas Center for Superconductivity's Energy Materials Program at the University of ...

Axonics Modulation Technologies, Inc.

Axonics, based in Irvine, Calif., is a privately held venture-backed pre-revenue company developing novel implantable neuromodulation technology licensed from The Alfred Mann Foundation directed toward a number of clinical indications, including the treatment of chronic pain and overactive bladder.

Trans Ova Genetics

Trans Ova Genetics grew out a desire to provide superior reproductive technology to seedstock producers in the Midwest. In 1980 Dr. David Faber and Dr. Daryl Funk had the foresight to provide "on farm" embryo transfer services in conjunction with their large animal veterinary practice. In a very short period of time, the demand for embryo transfer services grew significantly, and a limited "in cli...

SinuSys Corp.

Chronic sinusitis affects more than 31 million people in the United States. It is more prevalent than heart disease and asthma, and has a greater impact on patients’ quality of life than chronic back pain or congestive heart failure. The U.S. healthcare system currently spends more than $8 billion annually on improving the health of patients with sinu...

American Society of Interventional Pain Physicians

ASIPP's mission statement is to promote the development and practice of safe, high quality, cost-effective Interventional Pain Management techniques for the diagnosis and treatment of pain and related disorders, and to ensure patient access to these interventions. Founded in 1998 by Chairman of the Board and CEO Laxmaiah Manchikanti, MD, ASIPP is a rapidly growing not-for-profit organization that...

The Finnish Breast Cancer Group

The study, led by the Finnish Breast Cancer Group, was a large open-label, two-arm, randomised multicentre phase III study in women with early breast cancer. 1,500 patients in Finland and Sweden with no distant metastases who had an intermediate to high risk of recurrence within five years from the time of diagnosis, were recruited to the study.

Zogenix, Inc.

Zogenix, Inc., with offices in Emeryville and San Diego, Calif., is a privately held pharmaceutical company focused on the development and commercialization of medicines to treat neuroscience disorders and pain. The company is commercially focused on SUMAVEL(TM) DosePro(TM) (sumatriptan injection) needle-free delivery system, which launched in January 2010, for the acute treatment of migraine and ...

Sanofi Genzyme

Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.

Tranderma Pharmaceuticals Inc

Transderma Pharmaceuticals Inc. was founded by Pharmacists in collaboration with pharmaceutical formulation experts with a commitment to discover and manufacture topical delivery systems to address the growing need for effective trans -cellular drug delivery. Transdema launched its pre-mixed Premium Lecithin Organogel Base (PLO Gel) along with its range on PLO Kits in 2000. Subsequent product deve...

Coastal Orthopedics and Pain Management

Coastal Orthopedics & Sports MedicinePain Management has been serving the Sarasota-Bradenton area for over thirty years. Coastal Orthopedics is comprised of a group of over 15 specialty and sub-specialty trained orthopedic surgeons and pain management physicians focusing on the care and treatment of patients. Our pain management physicians work with patients to receive treatment focused on restori...

Cognetix, Inc.

Cognetix is a private drug discovery and development company located in Salt Lake City, Utah, focused on commercializing conopeptide-based pharmaceuticals. Conopeptides are bioactive peptides in the venom of marine cone snails. The Company is currently in clinical trials investigating its lead compound, CGX-1160, for the treatment of chronic intractable pain. The Company has a strong drug discover...

Nevro Corp.

Nevro Corp., headquartered in Menlo Park, California, is a privately-held medical device company founded in 2007 to provide advances in chronic pain relief through neuromodulation technology. The Nevro Spinal Cord Stimulation System received CE mark in 2010 and is now commercially available at leading centers outside the United States. For more information...

i3 Statprobe

Because we're strong in every area, you can outsource an entire study to i3 Statprobe, or outsource, for example, only the statistical programming for a single study. Or you can outsource only the statistical programming for every study. Use us any way you want to, we encourage it. For example, we'll provide a dedicated team of specialists (say, data coordinators or statistical programmers) to wor...

Probably Relevant

OKYO Pharma Limited

OKYO Pharma Limited (LSE: OKYO) is a life sciences and biotechnology company admitted to listing on the standard segment of the Official List of the UK Financial Conduct Authority and to trading on the Main Market for listed securities of the London Stock Exchange plc. OKYO is focusing on the discovery and development of novel molecules to treat inflammatory dry eye diseases and chronic pain.

St. Jude Medical

St. Jude Medical is dedicated to making life better for cardiac, neurological, and chronic pain patients worldwide through excellence in medical device technology and services. The company has five major focus areas that include: Cardiac rhythm management, Atrial fibrillation,Cardiac surgery,Cardiology, Neuromodulation

More From BioPortfolio on "Trans-MAPP II Study of Urologic Chronic Pelvin Pain"

Quick Search

Corporate Database Quicklinks